We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Earlier FDA-Devicemaker Talks Could Ease Postmarket Study Process
Earlier FDA-Devicemaker Talks Could Ease Postmarket Study Process
April 11, 2012
The FDA will consider adding a mandatory pre-522 discussion period before issuing postmarket surveillance orders, officials at a March public workshop on the process said.